Avoro Capital Advisors LLC Vera Therapeutics, Inc. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 6,300,000 shares of VERA stock, worth $133 Million. This represents 2.71% of its overall portfolio holdings.
Number of Shares
6,300,000
Previous 5,701,900
10.49%
Holding current value
$133 Million
Previous $137 Million
8.37%
% of portfolio
2.71%
Previous 2.22%
Shares
5 transactions
Others Institutions Holding VERA
# of Institutions
199Shares Held
64.6MCall Options Held
1.58MPut Options Held
365K-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$94.7 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$72.4 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$70.8 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY3.1MShares$65.5 Million3.85% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $572M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...